Back to News
Market Impact: 0.55

Rolls-Royce charting a steady flightpath

UBS
Company FundamentalsCorporate Guidance & OutlookAnalyst EstimatesAnalyst InsightsCorporate EarningsTechnology & InnovationInfrastructure & DefenseInvestor Sentiment & Positioning
Rolls-Royce charting a steady flightpath

Rolls-Royce Holdings PLC is maintaining a steady turnaround trajectory, with UBS anticipating its November trading update will reiterate 2025 guidance and offer upbeat commentary without surprises. While civil aerospace engine flying hours are tracking at the lower end of guidance (106% of 2019 levels vs. 110-115% target), investor focus has shifted to strong margins in aftermarket servicing and parts. Demand remains firm in defense and power systems benefit from data center growth, with small modular reactors providing a longer-term driver. UBS raised its price target to £13.50, implying 16% upside, reinforcing confidence in the company's ongoing progress.

Analysis

Rolls-Royce Holdings PLC's forthcoming November trading update is anticipated by UBS to affirm the steady progress of its turnaround strategy, with no significant deviations from its 2025 guidance. While a key metric, civil aerospace engine flying hours, is tracking at the lower end of the company's target range—currently at 106% of 2019 levels against a 110–115% goal—investor sentiment has shifted towards more lucrative areas. The market is now focused on the aftermarket segment, where servicing and parts are generating strong margins, effectively compensating for the slightly slower recovery in flight activity. The company's diversified portfolio provides further stability, with firm demand reported in its defence division and its power systems unit benefiting directly from the expansion of data centres. Looking forward, the small modular reactor (SMR) program is being positioned as a significant long-term growth driver. Reflecting this positive but measured outlook, UBS has increased its price target from £13.10 to £13.50, suggesting a potential 16% upside from the current share price of £11.64.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.